A kind of belinostat derivative based on formic acid and its preparation method and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG MEDICAL COLLEGE
- Publication Date
- 2020-04-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of antineoplastic drugs, in particular to a formic acid-based belistat derivative and its preparation method and application. Background technique
[0002] Belinostat Belongs to the hydroxamic acid class of histone deacetylase inhibitors (HDACi). The overexpression or abnormal regulation of histone deacetylase (HDAC) will lead to excessive deacetylation of histones, which will remodel chromatin into a configuration that inhibits transcription, resulting in a decrease in the expression of corresponding genes, leading to carcinogenesis. Therefore, inhibition of HDACs is considered a promising anticancer drug target. Belinostat can directly act on the abnormal expression of genes, thereby inhibiting and correcting the excessive proliferation and abnormal differentiation of tumor cells. For common drug resistance problems, it can also be used in combination with drugs with other mechanisms of action. Belinostat can ef...